WAVE Life Sciences Competitors, Revenue, Alternatives and Pricing

Claim your profile


Boston, MA USA
Total Funding:$227.8M
Lead Investor(s):Teva

Estimated Revenue & Financials

  • WAVE Life Sciences's estimated annual revenue is currently $49.6M per year.(?)
  • WAVE Life Sciences received $93.4M in venture funding in April 2017.
  • WAVE Life Sciences's estimated revenue per employee is $155,000
  • WAVE Life Sciences's total funding is $227.8M.

Employee Data

  • WAVE Life Sciences has 320 Employees.(?)
  • WAVE Life Sciences grew their employee count by 33% last year.
  • WAVE Life Sciences currently has 36 job openings.

Wave Life Sciences Ltd. (NASDAQ: WVE) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. Given the unique versatility of its chemistry platform, Wave's pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.